INAB
IN8bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website in8bio.com
- Employees(FY) 31
- ISIN US45674E1091
Performance
+1.98%
1W
+5.07%
1M
-7.21%
3M
+11.85%
6M
-25.36%
YTD
-62.95%
1Y
Profile
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Technical Analysis of INAB 2024-05-10
Overview:
In analyzing the technical indicators for INAB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-05-13 22:00
- 2024-05-12 20:00
- 2024-05-09 10:57
INAB Stock Earnings: IN8bio Misses EPS for Q1 2024(Investorplace)
- 2024-05-09 04:00
- 2024-04-29 18:05
- 2024-04-23 20:00
- 2024-04-16 04:05
- 2024-04-09 04:30
- 2024-03-14 09:54
INAB Stock Earnings: IN8bio Misses EPS for Q4 2023(Investorplace)
- 2024-03-14 04:00
- 2024-03-05 03:30
- 2024-02-25 19:00
IN8bio to Present at Upcoming Investor Conferences(Businesswire)
- 2024-02-13 19:00
- 2024-01-03 19:00
- 2023-12-11 03:05
- 2023-12-10 20:00
- 2023-12-06 19:00
IN8bio Appoints Dr. Corinne Epperly to Board of Directors(Globenewswire)
- 2023-12-04 19:00
- 2023-11-19 18:00
- 2023-11-09 18:00
- 2023-11-09 03:00
- 2023-11-05 19:00
- 2023-11-03 00:00
- 2023-11-01 21:17
- 2023-10-31 20:00
- 2023-10-11 20:00
- 2023-09-28 20:00
- 2023-09-25 20:00
- 2023-09-19 20:00
- 2023-09-18 20:03
Page 1 of 4
previousnext